TIOTROPIUM
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4.3M | 774 | 36 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.3M | 774 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE DAILY ADMINISTRATION OF LUPIN TIOTROPIUM BROMIDE INHALATION POWDER COMPARED TO SPIRIVA HANDIHALER AND PLACEBO IN PATIENTS WITH COPD INCLUDING A 12-WEEK OPEN LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $4.3M | 36 |
Top Doctors Receiving Payments for TIOTROPIUM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | North Dartmouth, MA | $2.2M | 387 |
| , M.D | Allergy | Medford, OR | $224,313 | 10 |
| , MD | Allergy & Immunology | New Braunfels, TX | $183,192 | 14 |
| , M.D | Allergy & Immunology | Raleigh, NC | $139,690 | 14 |
| , MD | Pulmonary Disease | Andalusia, AL | $89,490 | 10 |
| Jan Westerman | Critical Care Medicine | Charlotte, NC | $84,784 | 9 |
| , MD | Allergy & Immunology | North Dartmouth, MA | $82,658 | 10 |
| , M.D | Specialist | Columbus, OH | $81,338 | 13 |
| , MD | Pulmonary Disease | Westminster, CA | $78,742 | 11 |
| , DO | Internal Medicine | Clinton, SC | $77,309 | 20 |
| , M.D | Sleep Medicine | Rock Hill, SC | $74,297 | 13 |
| , MD | Pulmonary Disease | Dunedin, FL | $71,913 | 7 |
| , MD | Critical Care Medicine | Spartanburg, SC | $70,378 | 19 |
| , MD | Allergy & Immunology | Colorado Springs, CO | $70,118 | 11 |
| , MD | Pulmonary Disease | Spartanburg, SC | $64,067 | 26 |
| , M.D | Pulmonary Disease | Seneca, SC | $64,047 | 12 |
| Lyndon Mansfield | — | El Paso, TX | $60,387 | 11 |
| , M.D | Specialist | Saint Louis, MO | $58,217 | 10 |
| , MD PA | Internal Medicine | Clearwater, FL | $54,161 | 28 |
| , MD | Pulmonary Disease | Spartanburg, SC | $47,946 | 9 |
| , MD | Pulmonary Disease | Mckinney, TX | $47,540 | 13 |
| , M.D | Pulmonary Disease | Coon Rapids, MN | $47,332 | 6 |
| , MD | Allergy & Immunology | Upland, CA | $46,691 | 7 |
| , MD | Hospice and Palliative Medicine | Knoxville, TN | $46,064 | 15 |
| , MD | Critical Care Medicine | Spartanburg, SC | $43,311 | 18 |
Manufacturing Companies
- Lupin Inc. $4.3M
Product Information
- Type Drug
- Total Payments $4.3M
- Total Doctors 36
- Transactions 774
About TIOTROPIUM
TIOTROPIUM is a drug associated with $4.3M in payments to 36 healthcare providers, recorded across 774 transactions in the CMS Open Payments database. The primary manufacturer is Lupin Inc..
Payment data is available from 2018 to 2018. In 2018, $4.3M was paid across 774 transactions to 36 doctors.
The most common payment nature for TIOTROPIUM is "Unspecified" ($4.3M, 100.0% of total).
TIOTROPIUM is associated with 1 research study, including "A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE DAILY ADMINISTRATION OF LUPIN TIOTROPIUM BROMIDE INHALATION POWDER COMPARED TO SPIRIVA HANDIHALER AND PLACEBO IN PATIENTS WITH COPD INCLUDING A 12-WEEK OPEN LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS" ($4.3M).